BioNJ’s Health Equity in Clinical Trials Initiative Overview
Fair access to clinical trials is necessary to improve the understanding of health outcomes in heterogeneous populations, expand access to medical advancements for these populations and bolster trust in the biopharma industry/health care system. BioNJ is committed to helping Patients Live Longer Better Lives. Expanding the reach of clinical trials is essential to ensure that all Patients can be represented, resulting in a greater understanding on the safety and efficacy profile of potential new therapies across all populations. The life sciences sector plays a critical role in advancing access to care and BioNJ believes that role can be expanded. We have a moral imperative that requires business solutions that address this critical need.
BioNJ is committed to improving health outcomes for all individuals. Therefore, we have launched BioNJ’s Health Equity in Clinical Trials Initiative which will consider concrete issues we can tackle with impact, identify long-term interventions, support companies to improve equity in their clinical trials, consider best practices and shape and impact policy.
A focus on Health Equity in Clinical Trials will help to realize:
- Improved health outcomes in all populations and an improved understanding of those outcomes
- Broadened access to potential treatment advances for all populations
- Bolstered confidence in the biopharmaceutical industry and health care system
- Identify and help develop the next generation of clinical trial leaders and community partners
Contact BioNJ at BioNJ@BioNJ.org to learn how you can get involved.
Deliverable:
- NJ Baseline – In partnership with Medidata, BioNJ ascertained a baseline of the recruitment of and participation in certain clinical trials by New Jersey’s Patient population versus other states from which to identify opportunities and challenges in recruiting a heterogenous population.
- MBA Business Plan Competition – BioNJ introduced a first-of-its-kind MBA Business Plan Case Competition to promote the next generation of clinical trial innovators and deliver useful protocols and successful models that can be used nationally to ensure heterogeneity in clinical trials and effectiveness of treatments for all populations.
- Connecting the Dots – BioNJ facilitated Connecting the Dots via a virtual platform featuring projects that our companies are undertaking for sharing of information and cross collaboration.
- Trust – Building trust is critical and must be built into each facet of the plan. This will be an overarching theme and incorporated into all aspects.
- Directory – Directory of ideas and talent as well as recognizing the efforts of individuals (including winning ideas, entries, competition participants, sponsors, and volunteers)
Ensuring Care for All:

Improving representation in clinical trials is essential to advancing our understanding of health outcomes for all. Every person should have the opportunity to “attain his or her full health potential.”
Health inequities are reflected in differences in length of life; quality of life; rates of disease, disability and death; severity of disease; and access to treatment.
The Drug Development/Clinical Trial Process & Impact:

Clinical Trials – What You Need to Know Video
BioNJ’s Health Equity in Clinical Trials Steering Committee:
Download a pdf of the Steering Committee List.
Sponsorship Opportunities:
Partnership Benefits for All Sponsors
- Beneficiary of the five key deliverables from the initiative (NJ Baseline, MBA Business Plan Competition, Connecting the Dots, Trust and Directory)
- Inclusion of Partner Organization’s Health Equity-related initiatives on BioNJ Health Equity web portal (thousands of global visitors expected on a monthly basis)
- Corporate logo on Health Equity web portal
- Recognition at MBA Business Plan Competition (reaching students in MBA, PharmD and MD programs from partner universities) and other initiative events
- Opportunity to distribute Health Equity-related whitepapers (sent to ~15,000 names) and thought leadership via BioNJ social media (reaching 8,000+ users across five platforms)
- Participation in collective effort towards generating solutions and innovating
- Inclusion in op-eds highlighting New Jersey’s leadership role in HEQ
In addition to the above, the following Sponsorship Categories receive:
Champion – $100,000 – Limited to 6
- Organization featured as Champion and Trusted Advisor on all promotional and informational materials
- Leadership role in BioNJ’s Health Equity in Clinical Trials Strategy
- Seat on BioNJ’s Health Equity in Clinical Trials Strategy Steering Committee
- Key role in determining direction of the work
- Organization representative prominently featured at related events and on all materials promoting the effort
- Organization featured as a Founder of the MBA Business Plan Competition
- Opportunity to serve as a Judge for MBA Business Plan Competition
- Opportunity to showcase organization’s efforts to increase diversity in clinical trials during MBA Business Plan Competition
- Opportunity to interact with students directly during the MBA Business Plan Competition
Changemaker – $75,000
- Organization featured as Changemaker on all promotional and informational materials
- Seat on BioNJ’s Health Equity in Clinical Trials Strategy Steering Committee
- Key role in determining direction of the work
- Organizational representative featured as Committee Member on Health Equity web portal
- Organization featured as a Supporter of the MBA Business Plan Competition
- Opportunity to serve as a Judge for the MBA Business Plan Competition
- Opportunity to interact with students directly during the MBA Business Plan Competition
Connector – $50,000
- Organization featured as Connector on select promotional and informational materials
- Seat on BioNJ’s Health Equity in Clinical Trials Strategy Steering Committee
- Organizational representative featured as Committee Member on Health Equity web portal
- Organization featured as a Supporter of the MBA Business Plan Competition
Contributor – In Kind
- Organization featured as an In-Kind Contributor on select promotional and informational materials
- Opportunity to contribute tangible efforts to move the work forward
- Organization featured as a Supporter of that specific area of work of contribution
Contact Us to Learn More
To discuss your interest in supporting this initiative or for additional information:
Ian McLaughlin, Ph.D.
Executive Director, Government Affairs
IMcLaughlin@BioNJ.org
609-890-3185















